Analyst Ratings for Optimer Pharmaceuticals (OPTR)
OPTR Rating Summary
OPTR Price Target Summary
- Highest: $25.00 (ThinkEquity)
- Lowest: $10.00 (Citadel Securities)
- Average: $17.70
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$17.70 (+18.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2013 | Baird | Downgrade | Neutral (Outperform) |
16.00 (N/A) |
14.92 | 14.97 | 0.34% | Details |
| 5/10/2013 | Needham & Company | Downgrade | Hold (Buy) |
N/A (N/A) |
14.92 | 14.97 | 0.34% | Details |
| 3/1/2013 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
12.12 | 14.97 | 23.51% | Details |
| 10/9/2012 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
11.46 | 14.97 | 30.63% | Details |
| 10/4/2012 | Morgan Stanley | New Coverage | Underweight (N/A) |
11.00 (N/A) |
12.82 | 14.97 | 16.77% | Details |
| 9/19/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
25.00 (N/A) |
14.49 | 14.97 | 3.31% | Details |
| 9/18/2012 | BofA/Merrill Lynch | Downgrade | Underperform (Buy) |
N/A (N/A) |
15.51 | 14.97 | -3.48% | Details |
| 7/12/2012 | Canaccord Genuity » Updated 8/1/2012 |
New Coverage | Buy (N/A) |
22.00 (N/A) |
15.03 | 14.97 | -0.4% | Details |
| 6/15/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
20.00 (N/A) |
15.37 | 14.97 | -2.6% | Details |
| 5/14/2012 | ThinkEquity | New Coverage | Buy (N/A) |
25.00 (N/A) |
15.04 | 14.97 | -0.47% | Details |
| 12/9/2011 | WJB Capital | New Coverage | Hold (N/A) |
11.00 (N/A) |
11.85 | 14.97 | 26.33% | Details |
| 9/21/2011 | Brean Capital | New Coverage | Buy (N/A) |
20.00 (N/A) |
16.12 | 14.97 | -7.13% | Details |
| 8/8/2011 | Citadel Securities | New Coverage | Neutral (N/A) |
10.00 (N/A) |
8.59 | 14.97 | 74.27% | Details |
| 8/5/2010 | Piper Jaffray | Downgrade | Neutral (N/A) |
N/A (N/A) |
9.15 | 14.97 | 63.61% | Details |
